Łuczak E - Search Results

1

Studies towards biocompatibility of PAMAM dendrimers--overall hemostasis potential and integrity of the human aortic endothelial barrier.

Markowicz-Piasecka M, Łuczak E, Chałubiński M, Broncel M, Mikiciuk-Olasik E, Sikora J. Markowicz-Piasecka M, et al. Among authors: luczak e. Int J Pharm. 2014 Oct 1;473(1-2):158-69. doi: 10.1016/j.ijpharm.2014.07.002. Epub 2014 Jul 3. Int J Pharm. 2014. PMID: 24998508

2

IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms.

Chalubinski M, Wojdan K, Luczak E, Gorzelak P, Borowiec M, Gajewski A, Rudnicka K, Chmiela M, Broncel M. Chalubinski M, et al. Among authors: luczak e. Vascul Pharmacol. 2015 Oct;73:57-63. doi: 10.1016/j.vph.2015.07.012. Epub 2015 Jul 29. Vascul Pharmacol. 2015. PMID: 26231284

3

Endothelial integrity may be regulated by a specific antigen via an IgE-mediated mechanism.

Gorzelak-Pabis P, Luczak E, Wojdan K, Antosik K, Borowiec M, Broncel M, Chalubinski M. Gorzelak-Pabis P, et al. Among authors: luczak e. Postepy Hig Med Dosw (Online). 2017 Mar 2;71(0):162-169. doi: 10.5604/01.3001.0010.3800. Postepy Hig Med Dosw (Online). 2017. PMID: 28258676 Free article.

4

IL-22 modulates inflammatory properties of human primary aortic smooth muscle cells.

Gorzelak-Pabis P, Chałubiński M, Wojdan K, Łuczak E, Borowiec M, Broncel M. Gorzelak-Pabis P, et al. Among authors: luczak e. Adv Clin Exp Med. 2017 May-Jun;26(3):461-466. doi: 10.17219/acem/62218. Adv Clin Exp Med. 2017. PMID: 28791821 Free article.

5

Escherichia coli lipopolysaccharide may affect the endothelial barrier and IL-10 expression of apolipoprotein B100-pulsed dendritic cells.

Chalubinski M, Wojdan K, Luczak E, Gorzelak-Pabis P, Kluszczynska K, Borowiec M, Gajewski A, Rudnicka K, Chmiela M, Broncel M. Chalubinski M, et al. Among authors: luczak e. APMIS. 2020 Jan;128(1):10-19. doi: 10.1111/apm.12999. APMIS. 2020. PMID: 31642122

6

[The effect of 7-ketocholesterol on surface ICAM-1 and PECAM-1 expression in human aortic endothelial cells].

Dorantowicz R, Łuczak E, Broncel M. Dorantowicz R, et al. Among authors: luczak e. Pol Merkur Lekarski. 2014 Apr;36(214):233-9. Pol Merkur Lekarski. 2014. PMID: 24868894 Polish.

7

Innate lymphoid cells type 2 - emerging immune regulators of obesity and atherosclerosis.

Chalubinski M, Luczak E, Wojdan K, Gorzelak-Pabis P, Broncel M. Chalubinski M, et al. Among authors: luczak e. Immunol Lett. 2016 Nov;179:43-46. doi: 10.1016/j.imlet.2016.09.007. Epub 2016 Sep 16. Immunol Lett. 2016. PMID: 27646628 Review.

8

Increased plasma concentrations of interleukin 35 in patients with coronary artery disease.

Gorzelak-Pabiś P, Chalubinski M, Wojdan K, Luczak E, Duraj I, Mozdzan M, Broncel M. Gorzelak-Pabiś P, et al. Among authors: luczak e. Arch Med Sci. 2017 Jun;13(4):778-784. doi: 10.5114/aoms.2016.63751. Epub 2016 Nov 18. Arch Med Sci. 2017. PMID: 28721145 Free PMC article.

9

The influence of statin monotherapy and statin-ezetimibe combined therapy on FoxP3 and IL 10 mRNA expression in patients with coronary artery disease.

Jackowska P, Chałubiński M, Łuczak E, Wojdan K, Gorzelak-Pabis P, Olszewska-Banaszczyk M, Broncel M. Jackowska P, et al. Among authors: luczak e. Adv Clin Exp Med. 2019 Sep;28(9):1243-1248. doi: 10.17219/acem/108627. Adv Clin Exp Med. 2019. PMID: 31430072 Free article. Clinical Trial.

10

Troglitazone, a PPAR-γ agonist, decreases LTC₄ concentration in mononuclear cells in patients with asthma.

Luczak E, Wieczfinska J, Sokolowska M, Pniewska E, Luczynska D, Pawliczak R. Luczak E, et al. Pharmacol Rep. 2017 Dec;69(6):1315-1321. doi: 10.1016/j.pharep.2017.05.006. Epub 2017 May 24. Pharmacol Rep. 2017. PMID: 29128815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters